Evgen Pharma (EVG)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 3.80p
   
  • Change Today:
      0.000p
  • 52 Week High: 7.10
  • 52 Week Low: 2.85
  • Currency: UK Pounds
  • Shares Issued: 274.89m
  • Volume: 100,057
  • Market Cap: £10.45m
  • RiskGrade: 304

Regulatory News

Preliminary results from Phase 1b study 22-Mar-2023 07:00 RNS
Price Monitoring Extension 16-Mar-2023 14:00 RNS
Second Price Monitoring Extn 16-Mar-2023 11:05 RNS
Price Monitoring Extension 16-Mar-2023 11:00 RNS
No exposure to Silicon Valley Bank 13-Mar-2023 07:00 RNS
Clinical trial update 25-Jan-2023 07:00 RNS
Grant of Options - Director/PDMR Shareholding 14-Dec-2022 17:08 RNS
Half-year Report 08-Dec-2022 07:00 RNS
Notice of Half Year Results 02-Dec-2022 07:00 RNS
Second Price Monitoring Extn 30-Nov-2022 14:06 RNS
Price Monitoring Extension 30-Nov-2022 14:00 RNS
Study started of new SFX-01 tablet formulation 16-Nov-2022 07:00 RNS
Second Price Monitoring Extn 21-Oct-2022 11:05 RNS
Price Monitoring Extension 21-Oct-2022 11:00 RNS
Second Price Monitoring Extn 12-Oct-2022 16:41 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Evgen Pharma Market Data

Currency UK Pounds
Share Price 3.80p
Change Today 0.000p
% Change 0.00 %
52 Week High 7.10
52 Week Low 2.85
Volume 100,057
Shares Issued 274.89m
Market Cap £10.45m
RiskGrade 304

Evgen Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
10.34% below the market average10.34% below the market average10.34% below the market average10.34% below the market average10.34% below the market average
49.15% above the sector average49.15% above the sector average49.15% above the sector average49.15% above the sector average49.15% above the sector average
Price Trend
26.24% above the market average26.24% above the market average26.24% above the market average26.24% above the market average26.24% above the market average
46.03% above the sector average46.03% above the sector average46.03% above the sector average46.03% above the sector average46.03% above the sector average
Income Not Available
Growth Not Available

Evgen Pharma Dividends

No dividends found

Trades for 29-Mar-2023

Time Volume / Share Price
16:35 100 @ 3.70p
15:41 7,371 @ 3.75p
15:08 68,007 @ 3.80p
10:12 23,310 @ 3.74p
08:53 1,269 @ 3.80p

Evgen Pharma Key Personnel

CFO Richard Moulson
CEO Huw Jones

Top of Page